Related Experiment Video
Updated: Jun 12, 2026
08:56
Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
[From willow bark to acetylsalicylic acid]
Svend Norn1, Henrik Permin, Poul R Kruse
1Farmakologisk Afdeling, H. Lundbeck & Co. ksnorn@post.cybercity.dk
Dansk Medicinhistorisk Arbog
|June 1, 2010
Summary
Acetylsalicylic acid, a widely used drug, has a long history from natural sources to modern synthesis. Its anti-inflammatory and pain-relieving properties have been recognized for centuries, with ongoing research revealing new therapeutic applications.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- History of Medicine
Context:
- Acetylsalicylic acid (Aspirin) is a globally significant pharmaceutical.
- Its origins trace back to natural salicylates found in willow and poplar trees.
- Historical use of these natural remedies dates back to ancient civilizations for pain, fever, and inflammation.
Purpose:
- To provide a historical overview of acetylsalicylic acid (Aspirin).
- To highlight the evolution from natural remedies to synthetic drug development.
- To underscore the enduring relevance and ongoing research into Aspirin's therapeutic effects.
Summary:
- The historical use of salicylates from willow bark for medicinal purposes is documented from ancient times through the Middle Ages.
- Key milestones include the first clinical trial of willow bark by Edward Stone in 1763 and the description of antirheumatic effects.
- The synthesis of acetylsalicylic acid by Charles Gerhardt and Felix Hoffmann paved the way for its widespread use as Aspirin, with its mechanism elucidated by John Vane in 1971.
Impact:
- Acetylsalicylic acid (Aspirin) remains a vital medication with recognized benefits for pain, fever, and rheumatic conditions.
- Its antithrombotic effects are clinically significant.
- Current research continues to uncover new therapeutic potentials, demonstrating Aspirin's status as a dynamic and evolving drug.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:26Acute Inflammation I: Inflammatory Response
Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
01:29Spasmolytic Agents: Chemical Classification
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...